Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ETM.2015.2354PMID 26136915PMCID PMC4471765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ndogenous peptides as risk markers to assess the development of nsulin resistance

  2014cited by this paper
• Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection.

  2014cited by this paper
• Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet

  2014influential reference
• Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense?

  2013cited by this paper
• Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

  2013cited by this paper
• Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome.

  2013cited by this paper
• Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.

  2013cited by this paper
• Central nervous system control of metabolism

  2012cited by this paper
• Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis

  2012cited by this paper
• Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens.

  2011influential reference
• Fetuin-A: a multifunctional protein.

  2011influential reference
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome

  2010cited by this paper
• Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.

  2010cited by this paper
• Mortality attributable to diabetes: estimates for the year 2010.

  2010cited by this paper
• Insulin enhances glucose-stimulated insulin secretion in healthy humans

  2010cited by this paper
• Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

  2010cited by this paper
• Theory and Practice of Histological Techniques

  2009cited by this paper
• Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states.

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2009cited by this paper
• Theory and Practice of Histological Techniques, 6th Edition

  2008cited by this paper
• [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].

  2007cited by this paper
• Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

  2007cited by this paper
• Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes.

  2007cited by this paper
• Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes

  2007cited by this paper
• Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance

  2006cited by this paper
• Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol.

  2006cited by this paper
• Calyculin and okadaic acid promote perilipin phosphorylation and increase lipolysis in primary rat adipocytes.

  2006cited by this paper
• Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell

  2006cited by this paper
• Molecular control of cell cycle progression in the pancreatic beta-cell.

  2006cited by this paper
• Mechanisms linking obesity to insulin resistance and type 2 diabetes

  2006cited by this paper
• Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.

  2005cited by this paper
• Type 2 diabetes: principles of pathogenesis and therapy

  2005cited by this paper
• Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

  2005influential reference
• The insulin resistance syndrome: definition and dietary approaches to treatment.

  2005cited by this paper
• Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

  2005cited by this paper
• Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.

  2004cited by this paper
• Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

  2004cited by this paper
• Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.

  2004cited by this paper
• Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302*

  2004influential reference
• The Development of Beta-cell Mass: Recent Progress and Potential Role of GLP-1

  2004cited by this paper
• β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

  2003cited by this paper
• Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

  2003cited by this paper
• Metformin: new understandings, new uses.

  2003cited by this paper
• Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation

  2003cited by this paper
• Metformin: An Update

  2002cited by this paper
• Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

  2002influential reference
• Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.

  2001cited by this paper
• Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.

  2001cited by this paper
• Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance.

  2001cited by this paper
• Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

  2000influential reference
• Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

  1999cited by this paper
• Effects of Metformin on Lactate Uptake and Gluconeogenesis in the Perfused Rat Liver

  1997cited by this paper
• PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

  1996cited by this paper
• Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*)

  1995influential reference
• Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.

  1995cited by this paper
• Regulation of gene transcription by polyunsaturated fatty acids.

  1993cited by this paper
• Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

  1992influential reference
• Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I ) expression through a peroxisome-proliferator-activated receptor α (PPARα)-independent pathway

  year unknowninfluential reference

• Influence of metformin on the expression of SESTRIN2, Nrf2, and TUG1 genes in the liver tissue of diabetic rats

  2025cites this paper
• Synergistic Effects of Naringenin and Metformin on Dyslipidemia and Glucose Regulation in High Fructose-Fed Rats

  2025cites this paper
• Metformin's impact on asprosin and FBN1 expression: Potential mechanisms beyond insulin sensitivity in type 2 diabetes in rats

  2024cites this paper
• Green Coffee Bean Extract Potentially Ameliorates Liver Injury due to HFD/STZ-Induced Diabetes in Rats

  2023cites this paper
• A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep

  2023cites this paper
• Hypoglycemia and anxiolysis mediated by levofloxacin treatment in diabetic rats

  2023cites this paper
• The Effects of Metformin Treatment on Diabetic Albino Rats' Pancreas, Liver, and Kidney Histology.

  2023cites this paper
• Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk

  2022cites this paper
• Chilean pepper (Schinus polygamus) ameliorates the adverse effects of hyperglycaemia/dyslipidaemia in high fat diet/streptozotocin-induced type 2 diabetic rat model

  2022cites this paper
• Therapeutic Effect of P-Cymene on Lipid Profile, Liver Enzyme, and Akt/Mtor Pathway in Streptozotocin-Induced Diabetes Mellitus in Wistar Rats

  2022cites this paper
• Huang-Lian-Jie-Du decoction attenuates cognitive dysfunction of rats with type 2 diabetes by regulating autophagy and NLRP3 inflammasome activation.

  2022cites this paper
• The Effect of Antlion (Myrmeleon sp.) Extract Towards Histopathology Image of Pancreas in Diabetic Mice

  2021cites this paper
• Bee venom attenuates degenerative effects of diabetes associated with hyperlipidemia in rats.

  2021cites this paper
• Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers.

  2021cites this paper
• Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects

  2021cites this paper
• Sustained In Vitro and In Vivo Delivery of Metformin from Plant Pollen-Derived Composite Microcapsules

  2021influential citation
• The effect of Madhumeha Kusumakar Rasa – an Ayurved medicine – in insulin resistance

  2021cites this paper
• Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.

  2021cites this paper
• Pilosocereus gounellei (Cactaceae) stem extract decreases insulin resistance, inflammation, oxidative stress, and cardio-metabolic risk in diet-induced obese mice.

  2020cites this paper
• Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function

  2020cites this paper
• Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model

  2020cites this paper
• Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus

  2020cites this paper
• Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review

  2019cites this paper
• Effect of olive leaves extract on the antidiabetic effect of glyburide for possible herb-drug interaction

  2019cites this paper
• Fluconazole, a Fungal Cytochrome P450 Enzyme Inhibitor: The Potential Role in Augmenting Hepatotoxicity and Hyperinsulinemia Induced by Dexamethasone in Rats

  2019cites this paper
• Anti-hyperglycemic Effect of Torbangun (Coleus amboinicus Lour) Leaves Extract Through Liver and Muscle Glycogen Deposits in Streptozotocin-induced Hyperglycmic Sprague-Dawley Rats Model

  2019influential citation
• Influence of novel GPR119 agonist in combination with metformin and sitagliptin on glycemia, body weight and food intake in rats fed a high-fat diet

  2019cites this paper
• Investigating the Antidiabetic Effect of Metformin on Pyruvate Carboxylase

  2019cites this paper
• Metformin improves ovarian follicle dynamics by reducing theca cell proliferation and CYP-17 expression in an androgenized rat model

  2018cites this paper
• Modulation of the rod outer segment aerobic metabolism diminishes the production of radicals due to light absorption

  2018cites this paper
• Влияние комбинации агониста рецептора GPR119 с метформином и ситаглиптином на мозговой кровоток, функциональное состояние эндотелия и уровень липидов у животных, содержавшихся в условиях высокожировой и калорийной диеты

  2018cites this paper
• Influence of novel GPR119 agonist in combination with metformin and sitagliptin on lipid profile and endothelial function in rats fed a high-fat diet

  2018cites this paper
• Evaluation of Histopathological and Immunohistochemical Effects of Metformin HCl-Loaded Beads Formulations in Streptozotocin-Nicotinamide Induced Diabetic Rats

  2018cites this paper
• Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.

  2018cites this paper
• Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.

  2018cites this paper
• [Cerebroprotective activity of metformin, gosogliptin, citicoline and a novel GPR119 agonist in cerebral ischemia under experimental diabetes mellitus].

  2017cites this paper
• Polycystic ovary syndrome and nonalcoholic fatty liver disease

  2017cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.

  2017cites this paper
• Metformin ameliorates diabetes with metabolic syndrome induced changes in experimental rats

  2016cites this paper
• Влияние агониста рецептора GPR119 на уровень глюкозы, массу тела и потребление пищи у животных с ожирением, обусловленным высокожировой и углеводной диетой

  2016cites this paper
• INSULIN-MIMETIC ACTIVITY OF STEVIOSIDE ON DIABETIC RATS: BIOCHEMICAL, MOLECULAR AND HISTOPATHOLOGICAL STUDY

  2016cites this paper
• Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes

  2016cites this paper
• METFORMIN PYRUVATE CARBOXYLASE 1 Metformin Inhibition of Pyruvate Carboxylase in the Gluconeogenesis Pathway

  year unknowncites this paper
• A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and proli�cacy in sheep: the �rst exploratory study

  year unknowncites this paper